235 related articles for article (PubMed ID: 32774066)
1. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients.
Yao QY; Feng YD; Han P; Yang F; Song GQ
World J Gastroenterol; 2020 Jul; 26(27):3917-3928. PubMed ID: 32774066
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
Guo GH; Tan DM; Zhu PA; Liu F
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
[TBL] [Abstract][Full Text] [Related]
3. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
4. Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.
Ming D; Yu X; Guo R; Deng Y; Li J; Lin C; Su M; Lin Z; Su Z
Viral Immunol; 2015 May; 28(4):209-16. PubMed ID: 25710085
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
6. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway.
Xu M; Warner C; Duan X; Cheng Z; Jeyarajan AJ; Li W; Wang Y; Shao T; Salloum S; Chen PJ; Yu X; Chung RT; Lin W
J Hepatol; 2024 Jun; 80(6):868-881. PubMed ID: 38311121
[TBL] [Abstract][Full Text] [Related]
7. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
Huang CF; Sun CC; Zhao F; Zhang YD; Li DJ
J Gastroenterol; 2015 Apr; 50(4):480-90. PubMed ID: 25155445
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-β1-Induced OCT4/Nanog Pathway.
Li W; Duan X; Zhu C; Liu X; Jeyarajan AJ; Xu M; Tu Z; Sheng Q; Chen D; Zhu C; Shao T; Cheng Z; Salloum S; Schaefer EA; Kruger AJ; Holmes JA; Chung RT; Lin W
J Immunol; 2022 Feb; 208(3):672-684. PubMed ID: 35022275
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
10. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
Li ZJ; Ou-Yang PH; Han XP
Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264
[TBL] [Abstract][Full Text] [Related]
11. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-
Yao J; Lin C; Jiang J; Zhang X; Li F; Liu T; Diao H
Front Immunol; 2021; 12():666370. PubMed ID: 34168644
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10.
Xu Y; Liu F; He D; Han L; Zheng X; Hu M; Chen P
Immunobiology; 2023 Mar; 228(2):152315. PubMed ID: 36608595
[TBL] [Abstract][Full Text] [Related]
13. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
14. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
[TBL] [Abstract][Full Text] [Related]
15. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells.
Robert S; Gicquel T; Bodin A; Lagente V; Boichot E
PLoS One; 2016; 11(4):e0153118. PubMed ID: 27046197
[TBL] [Abstract][Full Text] [Related]
18. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.
Lin M; Chang Y; Xie F; Shi Y; Pang L; Chen D
Dig Dis Sci; 2018 Jan; 63(1):146-154. PubMed ID: 29196956
[TBL] [Abstract][Full Text] [Related]
19. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model.
Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY
J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]